OBJECTIVE: Single umbilical artery (SUA) is associated with fetal growth restriction as well as genetic and structural anomalies. Fetal echocardiogram has become a standard of care when a SUA is identified due to this association with congenital heart defects (CHD). This study aimed to characterize the type of CHD associated with SUA, the utility of ECHO after a negative targeted anatomy ultrasound and identify if a CHD was more common if there were non-cardiac anomalies also detected. STUDY DESIGN: Retrospective chart review of all patients with ultrasonographic findings of SUA and pathologic confirmation postnatally between 2010 and 2018 our Fetal Diagnostic Center. The rates and types of CHD in patients with isolated SUA and nonisolated SUA (additional anomalies detected on anatomical survey) were compared. The types of CHD were classified as major (structural) defects or minor (septal defects, anomalous vasculature, malrotation). RESULTS: 299 patients with pathologically confirmed SUA were identified between July 2010 and July 2018. Fifteen (5%) of these were confirmed to have aneuploidy either antenatally or postnatally and were excluded from the analysis. 247 (82.6%) fetuses had isolated SUA, and 37 (12.3%), had another concurrent fetal anomaly.
Of patients with isolated SUA, 4.5% had a congenital heart defect, while 16.2% of fetuses with another anomaly were found to have CHD. Isolated SUA did not confer less risk for major CHD vs. nonisolated SUA, (X 2 ¼ 1.41, p ¼ 0.23). Half of major anomalies were identified at the time of fetal echocardiogram and were not seen at the time of targeted anatomy sonogram.
CONCLUSION:
Even with isolated SUA, the incidence of CHD is increased over the baseline risk of the general population and should warrant additional screening via fetal echocardiogram. Furthermore, the type of CHD can be severe and require referral to a tertiary care center.
193 Individualized Growth Assessment in pregnancies complicated by fetal gastroschisis OBJECTIVE: Fetal gastroschisis is associated with IUGR and SGA. Prenatal US may overcall IUGR because the abdominal circumference and associated weight estimations can be underestimated by herniated viscera. Individualized Growth Assessment (IGA) evaluates fetal and neonatal growth based on serial US measurements, thus is different from conventional methods that use populationbased curves at fixed time points. Our goal was to assess the potential of IGA for separating normal and pathological growth in gastroschisis cases. STUDY DESIGN: Pregnancies with fetal gastroschisis that were managed and delivered at a single academic medical center were analyzed. Cases were classified into four groups by the presence of IUGR and SGA. IUGR was defined as US EFW <10 th percentile by Hadlock formula; SGA was defined as birthweight <10 th percentile by Fenton curve. Second and third trimester US fetal biometry and neonatal measurements were entered into iGAP software, which calculates fetal and neonatal growth pathology scores based on estimates of growth potential from 2 nd trimester growth velocities. Agreement between conventional US methods and IGA was assessed. RESULTS: Of 70 pregnancies with fetal gastroschisis delivered between 2009 and 2016 at a single center, 21 pregnancies with at least four US measurements were included. In the no IUGR/no SGA group (n¼12), there was 75% agreement (9/12) between IGA and conventional methods. IGA reported a negative prenatal growth score in three cases, but all showed a normal neonatal growth score. In the yes IUGR/yes SGA group (n¼5) there was 100% agreement between IGA and conventional methods in assessing prenatal growth restriction. However, IGA reported a negative neonatal growth score in only two (40%) of the cases. In the yes IUGR/no SGA group Poster Session I ajog.org S140 American Journal of Obstetrics & Gynecology Supplement to JANUARY 2019
